Ridaforolimus drug page Clinical trials

Trials with Ridaforolimus

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
0Recruiting
1Countries
59Planned patients

Showing 1–2 of 2

A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)
Finished Phase 1 47 patients NCT01243762

This is an open-label, two-part study to evaluate the safety and tolerability of combination treatment with dalotuzumab + MK-2206, dalotuzumab + MK-0752, or dalotuzumab + ridaforolimus (MK-8669). Part 1 of the study will determine the dose…

Nov 2010 – Mar 2013 Interventional
Ridaforolimus With Cetuximab: Adv Non-Small Cell Lung, Colorectal, Head & Neck Cancer
Finished Phase 1 12 patients NCT01212627

The main purpose of this study is to evaluate the best dose, safety and side effects of ridaforolimus when given with cetuximab for patients with head and neck, lung and colon cancer that has progressed after initial therapy. A second purp…

United States Sept 2010 – Apr 2013 Interventional